Search Results - "Strober, M D"

An uncommon case of thermal burn from repetitive implantable cardioverter-defibrillator shocks seen on positron emission tomography/computed tomography scan by Perez, Christopher, Banchs, Javier E., Strober, Mark D., Mixon, Timothy A.

Get full text

Neonatal Colonic Inflammation: An Epigenetic Trigger of Adult Disease by Strober, Warren, MD

Get full text

Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteers by Munabi, A K, Feuillan, P, Staton, R C, Rodbard, D, Chrousos, G P, Anderson, R E, Strober, M D, Loriaux, D L, Cutler, Jr, G B

“…We compared the adrenal steroid responses after synthetic ACTH-(1-24) (Cosyntropin) administration given by either continuous iv infusion or bolus injection in…”
Get more information

Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series by Shahriari, Neda, Strober, Bruce, Shahriari, Mona

Get full text

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients by Shahriari, Neda, Strober, Bruce, Shahriari, Mona

Get full text

Nuclear medicine in problems of fertility and impotence by Zuckier, L S, Strober, M D

“…Nuclear medicine techniques may be used to test fallopian tube patency and penile vascular inflow and outflow. Radionuclide hysterosalpingography (HSP) is a…”
Get more information

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference by Kalb, Robert E., MD, Strober, Bruce, MD, PhD, Weinstein, Gerald, MD, Lebwohl, Mark, MD

“…Background Methotrexate remains a valuable option for the treatment of psoriasis. This report will summarize studies regarding the use of methotrexate since…”
Get full text

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry by Silverberg, Jonathan I., Cronin, Angel, Jones, Eric A., Dave, Swapna S., McLean, Robert R., Greenberg, Jeffrey, Strober, Bruce, Bieber, Thomas, Gooderham, Melinda, Paller, Amy S., Simpson, Eric L.

Get full text

Methotrexate and cyclosporine in psoriasis revisited by Strober, Bruce E

“…Methotrexate and cyclosporine - as monotherapy or in combination with biologics or other drugs - still have an important place in the roster of therapeutic…”
Get more information

Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study by Papp, Kim, MD, PhD, Bachelez, Herve, MD, PhD, Costanzo, Antonio, MD, Foley, Peter, MD, Gooderham, Melinda, MD, Kaur, Primal, MD, Narbutt, Joanna, MD, PhD, Philipp, Sandra, MD, PhD, Spelman, Lynda, MD, Weglowska, Jolanta, MD, Zhang, Nan, PhD, Strober, Bruce, MD, PhD

“…Background ABP 501 is a biosimilar of adalimumab. Objective We sought to compare the efficacy and safety of ABP 501 with adalimumab. Methods This 52-week,…”
Get full text

Short and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data by Strober, Bruce, MD, PhD, Leonardi, Craig, MD, Papp, Kim A., MD, PhD, FRCPC, Mrowietz, Ulrich, MD, Ohtsuki, Mamitaro, MD, PhD, Bissonnette, Robert, MD, MSc, FRCPC, Ferris, Laura K., MD, PhD, Paul, Carle, MD, PhD, Lebwohl, Mark, MD, FAAD, Braun, Daniel K., MD, PhD, Mallbris, Lotus, MD, PhD, Wilhelm, Stefan, MD, Xu, Wen, PhD, Ljungberg, Anders, MD, Acharya, Nayan, MBBS, MRCP, MFPM, Reich, Kristian, MD, PhD

“…Background Safety of biologics is important when treating patients with psoriasis. Objective We sought to determine the safety of ixekizumab in psoriasis…”
Get full text

Clinical meaningfulness of complete skin clearance in psoriasis by Strober, Bruce, MD, PhD, Papp, Kim A., MD, PhD, Lebwohl, Mark, MD, Reich, Kristian, MD, Paul, Carle, MD, PhD, Blauvelt, Andrew, MD, Gordon, Kenneth B., MD, Milmont, Cassandra E., PhD, Viswanathan, Hema N., PhD, Li, Joanne, PhD, Pinto, Lionel, PhD, Harrison, David J., PhD, Kricorian, Greg, MD, Nirula, Ajay, MD, PhD, Klekotka, Paul, MD, PhD

“…Background New psoriasis therapies have increased the ability to achieve skin clearance. However, insufficient evidence exists on the impact of total skin…”
Get full text

Tumor necrosis factor inhibitors in psoriasis: an update by Kerdel, Francisco A, Strober, Bruce E

“…Three inhibitors of tumor necrosis factor (TNF) currently are approved for the treatment of psoriasis: etanercept, infliximab, and adalimumab. The other two…”
Get more information

Understanding therapeutic pathways and comorbidities in psoriasis by Gordon, Kenneth B, Strober, Bruce E

“…Psoriasis is now recognized as an immunologically mediated systemic disease that may be expressed in cutaneous and joint symptoms. Medications that were once…”
Get more information

Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder by Ananth, Amitha L., MD, Robichaux-Viehoever, Amy, MD, PhD, Kim, Young-Min, ​MD, Hanson-Kahn, Andrea, MS, CGC, Cox, Rachel, MS, CGC, Enns, Gregory M., MB, ChB, Strober, Jonathan, MD, Willing, Marcia, MD, Schlaggar, Bradley L., MD, PhD, Wu, Yvonne W., MD, MPH, Bernstein, Jonathan A., MD, PhD

“…Abstract Objectives Mutations in GNAO1 have been described in 11 patients to date. Although most of these individuals had epileptic encephalopathy, four…”
Get full text

Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-related Comorbidities by Shlyankevich, Julia, MD, Mehta, Nehal N., MD, MSCE, Krueger, James G., MD, PhD, Strober, Bruce, MD, PhD, Gudjonsson, Johann E., MD, PhD, Qureshi, Abrar A., MD, MPH, Tebbey, Paul W., PhD, MBA, Kimball, Alexandra Boer, MD, MPH

“…Abstract The International Psoriasis Council, a global nonprofit organization dedicated to advancing psoriasis research and treatment, led an initiative to…”
Get full text

Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis by Papp, Kim, MD, PhD, Menter, Alan, MD, Strober, Bruce, MD, PhD, Kricorian, Greg, MD, Thompson, Elizabeth H.Z., PhD, Milmont, Cassandra E., PhD, Nirula, Ajay, MD, PhD, Klekotka, Paul, MD, PhD

“…Background Novel therapies are needed for difficult-to-treat populations of patients with psoriasis. Objective We sought to assess the efficacy and safety of…”
Get full text

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials by Lebwohl, Mark, MD, Leonardi, Craig, MD, Griffiths, Christopher E.M., MD, Prinz, Jörg C., MD, Szapary, Philippe O., MD, MSCE, Yeilding, Newman, MD, Guzzo, Cynthia, MD, Li, Shu, MS, Hsu, Ming-Chun, PhD, Strober, Bruce, MD, PhD

“…Background Ustekinumab targets interleukin (IL)-12 and IL-23 in the treatment of moderate-to-severe psoriasis. Objective To evaluate overall pooled study data…”
Get full text

Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept by Strober, Bruce, MD, PhD, Gottlieb, Alice B., MD, PhD, Sherif, Bintu, MS, Mollon, Patrick, MD, MBA, MSc, Gilloteau, Isabelle, MSc, McLeod, Lori, PhD, Fox, Todd, PharmD, Mordin, Margaret, MS, Gnanasakthy, Ari, MSc, MBA, Papavassilis, Charis, MD, PhD, Lebwohl, Mark G., MD

“…Background Psoriasis is a chronic condition with negative impact on patients' quality of life that most often requires lifelong effective and safe treatment…”
Get full text

Infant Botulism: Review and Clinical Update by Rosow, Laura K., MD, Strober, Jonathan B., MD

“…Abstract Botulism is a rare neuromuscular condition, and multiple clinical forms are recognized. Infant botulism was first identified in the 1970s, and it…”
Get full text